PEPTONIC medical AB (publ)

NGM:PMED Stock Report

Market Cap: SEK 92.1m

PEPTONIC medical Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Erik Sundquist

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure3yrs
CEO ownership0.03%
Management average tenure3yrs
Board average tenure1yrs

Recent management updates

Recent updates

CEO

Erik Sundquist (53 yo)

3yrs

Tenure

Mr. Erik Sundquist, M.Sc. (Eng), serves as Chief Executive Officer at PEPTONIC medical AB (publ) since April 2021. He has been Marketing Director at PEPTONIC medical AB (publ) since October 1, 2017. He has...

Leadership Team

NamePositionTenureCompensationOwnership
Erik Sundquist
Chief Executive Officer3yrsno data0.025%
SEK 23.1k
Albert Lindgren
Chief Financial Officerless than a yearno datano data
Dan Markusson
Chief Operating Officer3yrsno data0.10%
SEK 92.2k
Heli Kurjanen
CEO of Lune Group Oyno datano data0.59%
SEK 540.4k

3.0yrs

Average Tenure

Experienced Management: PMED's management team is considered experienced (3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Tarek Shoeb
Director1.3yrsno datano data
Anders Blom
Chairman of the Boardless than a yearno datano data
Kristina Ingvar
Directorless than a yearno datano data
Mika Kurjanen
Board Member Lune Group Oy Ltdno datano datano data
Anders Norling
Independent Director1.9yrsno datano data
Daniel Rudeklint
Directorno datano datano data

1.0yrs

Average Tenure

54yo

Average Age

Experienced Board: PMED's board of directors are not considered experienced ( 1 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/04/29 01:32
End of Day Share Price 2024/01/31 00:00
Earnings2023/09/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

PEPTONIC medical AB (publ) is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Markus AugustssonCarlsquare AB
Joanna BoquistRedeye